Balance Sheet Data

ReShape Lifesciences Inc. (RSLS)

$0.1725

+0.01 (+5.44%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 5.552.942.9622.763.86180.521,247.778,624.9759,618.29412,098.62
Total Cash (%)
Account Receivables 0.924.102.622.812.1837.53259.431,793.2812,395.6985,682.56
Account Receivables (%)
Inventories 0.981.322.2433.6138.09263.261,819.7412,578.5886,946.72
Inventories (%)
Accounts Payable 1.634.263.653.471.9357.70398.852,756.9419,056.75131,725.67
Accounts Payable (%)
Capital Expenditure -0.05-0.01-0.39-0.35-0.13-2.40-16.62-114.85-793.91-5,487.73
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.